🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/04/2019 | 102,19 | 103,34 | 100,12 | 102,57 | +0,67% | 3,15% | 502.200 |
| 29/04/2019 | 105,46 | 105,68 | 101,72 | 101,89 | -2,86% | 3,75% | 582.800 |
| 26/04/2019 | 102,18 | 105,18 | 101,67 | 104,89 | +2,79% | 3,44% | 507.800 |
| 25/04/2019 | 103,27 | 103,90 | 100,96 | 102,04 | -1,41% | 2,85% | 488.500 |
| 24/04/2019 | 104,21 | 104,31 | 102,62 | 103,50 | -0,78% | 1,62% | 507.800 |
| 23/04/2019 | 99,56 | 105,00 | 99,21 | 104,31 | +5,53% | 5,82% | 952.400 |
| 22/04/2019 | 99,91 | 101,00 | 98,18 | 98,84 | -1,49% | 2,82% | 444.500 |
| 18/04/2019 | 101,36 | 102,40 | 98,77 | 100,34 | -0,31% | 3,58% | 652.200 |
| 17/04/2019 | 107,19 | 107,28 | 100,40 | 100,65 | -5,93% | 6,42% | 786.100 |
| 16/04/2019 | 108,60 | 108,85 | 106,38 | 107,00 | -0,91% | 2,27% | 326.300 |
| 15/04/2019 | 108,16 | 108,67 | 107,36 | 107,98 | +0,06% | 1,21% | 350.600 |
| 12/04/2019 | 110,39 | 110,53 | 106,98 | 107,91 | -1,82% | 3,22% | 429.400 |
| 11/04/2019 | 111,20 | 111,74 | 109,05 | 109,91 | -0,81% | 2,42% | 437.000 |
| 10/04/2019 | 110,66 | 111,35 | 110,08 | 110,81 | +0,14% | 1,15% | 454.400 |
| 09/04/2019 | 113,33 | 113,33 | 110,61 | 110,65 | -2,87% | 2,40% | 558.800 |
| 08/04/2019 | 117,45 | 118,66 | 113,80 | 113,92 | -5,70% | 4,14% | 698.800 |
| 05/04/2019 | 118,90 | 121,11 | 118,34 | 120,81 | +1,96% | 2,33% | 358.600 |
| 04/04/2019 | 117,62 | 118,60 | 116,73 | 118,49 | +0,94% | 1,59% | 336.400 |
| 03/04/2019 | 117,42 | 117,60 | 116,31 | 117,39 | +0,49% | 1,10% | 464.900 |
| 02/04/2019 | 118,15 | 118,74 | 116,75 | 116,82 | -0,93% | 1,68% | 279.300 |
| 01/04/2019 | 118,54 | 118,69 | 117,22 | 117,92 | +0,47% | 1,24% | 291.100 |
| 29/03/2019 | 118,25 | 118,86 | 116,84 | 117,37 | +0,14% | 1,71% | 454.800 |
| 28/03/2019 | 116,81 | 118,65 | 116,36 | 117,21 | +0,58% | 1,96% | 209.300 |
| 27/03/2019 | 118,16 | 118,92 | 116,29 | 116,53 | -1,30% | 2,23% | 335.500 |
| 26/03/2019 | 118,83 | 121,54 | 116,95 | 118,07 | -1,85% | 3,86% | 308.600 |
| 25/03/2019 | 120,90 | 122,17 | 119,19 | 120,29 | -0,42% | 2,46% | 346.500 |
| 22/03/2019 | 122,61 | 123,88 | 120,68 | 120,80 | -1,78% | 2,61% | 275.500 |
| 21/03/2019 | 120,84 | 123,69 | 119,18 | 122,99 | +1,44% | 3,73% | 473.500 |
| 20/03/2019 | 118,86 | 122,68 | 118,49 | 121,24 | +2,18% | 3,53% | 470.800 |
| 19/03/2019 | 119,30 | 120,54 | 118,21 | 118,65 | -0,17% | 1,95% | 267.300 |